全文获取类型
收费全文 | 5545篇 |
免费 | 320篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 368篇 |
妇产科学 | 80篇 |
基础医学 | 757篇 |
口腔科学 | 124篇 |
临床医学 | 446篇 |
内科学 | 1068篇 |
皮肤病学 | 115篇 |
神经病学 | 307篇 |
特种医学 | 117篇 |
外科学 | 793篇 |
综合类 | 193篇 |
一般理论 | 3篇 |
预防医学 | 331篇 |
眼科学 | 133篇 |
药学 | 562篇 |
1篇 | |
中国医学 | 41篇 |
肿瘤学 | 403篇 |
出版年
2023年 | 33篇 |
2022年 | 79篇 |
2021年 | 185篇 |
2020年 | 98篇 |
2019年 | 130篇 |
2018年 | 155篇 |
2017年 | 114篇 |
2016年 | 133篇 |
2015年 | 162篇 |
2014年 | 211篇 |
2013年 | 275篇 |
2012年 | 349篇 |
2011年 | 333篇 |
2010年 | 218篇 |
2009年 | 179篇 |
2008年 | 285篇 |
2007年 | 244篇 |
2006年 | 274篇 |
2005年 | 241篇 |
2004年 | 195篇 |
2003年 | 184篇 |
2002年 | 179篇 |
2001年 | 134篇 |
2000年 | 145篇 |
1999年 | 122篇 |
1998年 | 67篇 |
1997年 | 43篇 |
1996年 | 30篇 |
1995年 | 28篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 92篇 |
1991年 | 78篇 |
1990年 | 70篇 |
1989年 | 75篇 |
1988年 | 71篇 |
1987年 | 58篇 |
1986年 | 62篇 |
1985年 | 56篇 |
1984年 | 42篇 |
1983年 | 24篇 |
1982年 | 23篇 |
1979年 | 39篇 |
1977年 | 31篇 |
1975年 | 33篇 |
1974年 | 29篇 |
1973年 | 25篇 |
1972年 | 32篇 |
1971年 | 25篇 |
1968年 | 21篇 |
排序方式: 共有5911条查询结果,搜索用时 0 毫秒
71.
Z K Shikary S S Betrabet Z M Patel S Patel J V Joshi V S Toddywala S P Toddywala D M Patel K Jhaveri B N Saxena 《Contraception》1987,35(5):477-486
The transfer of levonorgestrel (LNG) from the maternal plasma via breast milk to the infant was studied in 38 fully lactating and breast-feeding women at 4-6 weeks postpartum, for a duration of 28 days. These volunteers were provided with LNG contraceptive treatment delivered through three, different routes of drug delivery system: (i) intrauterine devices impregnated with LNG (LNG-IUD); (ii) subdermal implant (Norplant (R)-2); and (iii) minipills (LNG 30 micrograms daily). On the first day after either the LNG-IUD (n = 14 women) or Norplant (R)-2 (n = 14 women) insertion, the maternal blood and breast milk samples were collected at 2, 4 and 8 hourly intervals. This was followed by daily collection of these samples as well as infant's blood from days 2 to 4 and thereafter on days 7, 14 and 28. For infant's blood samples from LNG minipill users (n = 10 women), only a single 4-hour sample was collected on the first day and no samples were collected on days 3 and 4. The rest of the schedule for collection of maternal blood and breast milk as well as infant's blood samples were the same in minipill users as for the other two treatment groups. The study revealed a lower LNG percentage transfer from maternal sera to breast milk--11.8 +/- 2, 7 +/- 2 and 8 +/- 1 and relatively higher percentage LNG transfer from breast milk to infant's sera--75 +/- 17, 68 +/- 20 and 32 +/- 3, in LNG-IUD, Norplant (R)-2 and minipill users, respectively. Therefore, LNG contraceptive steroid is transferred into the infant's circulation, the biological significance of which remains to be established. 相似文献
72.
73.
Hui Yu Zhengming Chen Karla V. Ballman Mark A. Watson Ramaswamy Govindan Irena Lanc David G. Beer Raphael Bueno Lucian R. Chirieac Michael Herman Chui Guoan Chen Wilbur A. Franklin David R. Gandara Carlo Genova Kristine A. Brovsky Mary-Beth M. Joshi Daniel T. Merrick William G. Richards Fred R. Hirsch 《Journal of thoracic oncology》2019,14(1):25-36
Objectives
Anti–programmed cell death 1 (PD-1)/programmed death ligand 1 (PD-L1) immunotherapy has demonstrated success in the treatment of advanced NSCLC. Recently, PD-1/PD-L1 blockade also has demonstrated interesting results in small trials of neoadjuvant treatment in stage IB to IIIA NSCLC. In addition, several clinical trials using anti–PD-1/PD-L1 immunotherapy as an adjuvant or neoadjuvant treatment in patients with resectable stage NSCLC are ongoing. However, few analyses of anti–PD-1/PD-L1 immunotherapy–related biomarkers in early-stage squamous cell lung carcinoma (SqCLC) have been reported. In this study, we evaluated PD-L1 protein expression, tumor mutation burden, and expression of an immune gene signature in early-stage SqCLC, providing data for identifying the potential role for patients with anti–PD-1/PD-L1 treatment in early-stage SqCLC.Methods
A total of 255 specimens from patients with early-stage SqCLC were identified within participating centers of the Strategic Partnering to Evaluate Cancer Signatures program. PD-L1 protein expression by immunohistochemistry was evaluated by using the Dako PD-L1 22C3 pharmDx kit on the Dako Link 48 auto-stainer (Dako, Carpinteria, CA). Tumor mutation burden (TMB) was calculated on the basis of data from targeted genome sequencing. The T-effector and interferon gamma (IFN-γ) gene signature was determined from Affymetrix gene chip data (Affymetrix, Santa Clara, CA) from frozen specimens.Results
The prevalence of PD-L1 expression was 9.8% at a tumor proportion score cutoff of at least 50%. PD-L1 mRNA and programmed cell death 1 ligand 2 mRNA positively correlated with PD-L1 protein expression on tumor cells (TCs) and tumor-infiltrating immune cells. PD-L1 protein expression on tumor-infiltrating immune cells was correlated with the T-effector and IFN-γ gene signature (p < 0.001), but not with TMB. For TCs, all of these biomarkers were independent of each other and neither PD-L1 protein expression, TMB, or T-effector and IFN-γ gene signatures were independently prognostic for patient outcomes.Conclusions
Evaluation of PD-L1 expression, TMB, and T-effector and IFN-γ gene signatures in the cohort with early-stage SqCLC found them to be independent of each other, and none was associated with overall survival. Our results also support the hypothesis that PD-L1 expression is regulated by an intrinsic mechanism on TCs and an adaptive mechanism on immune cells. 相似文献74.
75.
An unusual case of colitis 总被引:1,自引:0,他引:1
76.
Ebenezer Oni Oluseye Ogunmoroti Norrina Allen Mouaz H. A-Mallah Ron Blankstein Seth S. Martin Irfan Zeb Mary Cushman Parag H. Joshi Matthew J. Budoff Michael J. Blaha Roger S. Blumenthal Emir Veledar Khurram Nasir 《The American journal of medicine》2021,134(4):519-525
BackgroundThe American Heart Association (AHA) has defined Life's Simple 7 (LS7) as a measure of overall cardiovascular health . Nonalcoholic fatty liver disease (NAFLD) has been involved as a risk factor for cardiovascular disease. We evaluated the association between LS7 and NAFLD.MethodsWe evaluated participants form the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. Cardiovascular health score was calculated from the Life's Simple 7 metrics. A score of 0-8 was considered inadequate, 9-10 average, and 11-14 optimal. NAFLD was defined using noncontrast cardiac computed tomography (CT) and a liver/spleen attenuation ratio (L/S) < 1. Multivariable regression were performed to evaluate the association.ResultsOur cross-sectional analysis of 3901 participants showed 19% (n = 747) had optimal cardiovascular health, 33% (n = 1270) had average, and 48% (n = 1884) had inadequate. White participants were most likely to have an optimal score (51%, n = 378), whereas African American participants had the lowest proportion with optimal scores (16%, n = 120; P < 0.001). The overall prevalence of NAFLD was 18% with a distribution of 7%, 14%, and 25% in the optimal, average, and inadequate score categories, respectively (P < 0.001). Adjusted for risk factors, average and optimal health categories had lower odds of NAFLD compared to those with inadequate scores: odds ratio for average, 0.44 (95% confidence interval 0.36-0.54); optimal, odds ratio 0.19 (95% confidence interval 0.14-0.26). This association was similar across gender, race and age groups.ConclusionA more favorable cardiovascular health score was associated with a lower prevalence of NAFLD. This study may suggest a potential of Life's Simple 7 in the prevention of liver disease. 相似文献
77.
Anil Rana Jimi Marin Alex Monika Chauhan Gaurav Joshi Raj Kumar 《Medicinal chemistry research》2015,24(3):903-920
Past few decades have witnessed the dawn of new diseases in which cancer is a major problem and the race ensued to eradicate cancer by charting out various effective therapeutic regimens. Circumventing resistance issues and combating the toxicity and selectivity problems are matter-of-concern in cancer treatment. Persistent failure to ensure complete remission and eradication of cancer instigated the researchers to exploit the strategies of combining pharmacophores as targeted therapeutic agents. Momentous improvement in the pharmacokinetic as well as pharmacodynamic profile resulting in the enhancement of bioavailability was seen with the introduction of these pharmacophores. The scope of molecular hybridization can be clearly exemplified through the US-FDA approved estramustine and others such as CUDC-101, CBLC-137, PLX3397, E-3810, and CUDC-907 that are currently in different phases of clinical trials. This review seeks to highlight and discuss anti-proliferative activity of some important hybrid, dual, and multi-targeted pharmacophores reported to date along with their designs, structure activity relationships, scope, and limitations. Further, an emphasis has been made to summarize US-FDA approved as well as drugs currently undergoing clinical trials of anticancer drug development. 相似文献
78.
79.
Balram Bhairavi Joshi Harshad Wong Karen Kroeker Karen I. Dieleman Levinus A. Halloran Brendan P. Baumgart Daniel C. Peerani Farhad 《Digestive diseases and sciences》2021,66(11):3985-3992
Digestive Diseases and Sciences - While there is recent literature to support the discontinuation of 5-aminosalicylate (5-ASA) upon the initiation of biologics, continuing 5-ASA after treatment... 相似文献
80.
Gentle Sunder Shrestha Pankaj Joshi Santosh Chhetri Ragesh Karn Subhash Prasad Acharya 《Indian Journal of Critical Care Medicine》2015,19(5):283-285
Refractory and super-refractory status epilepticus is a life-threatening neurological emergency, associated with high morbidity and mortality. Treatment should be aimed to stop seizure and to avoid cerebral damage and another morbidity. Published data about effectiveness, safety and outcome of various therapies and treatment approaches are sparse and are mainly based on small case series and retrospective data. Here we report successful management of two cases of super-refractory status epilepticus refractory to anesthetic therapy with midazolam and complicated by septic shock, managed successfully with ketamine infusion. 相似文献